Publications by authors named "Jeff Lipton"

Claim this Profile
C
Cross-intolerance with bosutinib after prior tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia: long-term analysis of a phase I/II study.
Jorge E Cortes, Jeff H Lipton, Vamsi Kota, Fausto Castagnetti, Sarit Assouline

Haematologica· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety following bosutinib dose reduction in patients with Philadelphia chromosome‒positive leukemias.
Vamsi Kota, Tim H Brümmendorf, Carlo Gambacorti-Passerini, Jeff H Lipton, Dong-Wook Kim

Leuk Res· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung transplantation for late-onset non-infectious chronic pulmonary complications of allogenic hematopoietic stem cell transplant.
Peter Riddell, Ram Vasudevan-Nampoothiri, Jin Ma, Lianne G Singer, Jeff H Lipton

Respir Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival of head and neck squamous cell carcinoma after bone marrow transplant.
Catriona M Douglas, Ashock R Jethwa, Wael Hasan, Amy Liu, Ralph Gilbert, Jeff Lipton

Head Neck· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tyrosine Kinase Inhibitors in the Clinical Setting: A Conundrum of Choices.
Aniket Bankar, Jeff H Lipton

Acta Haematol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher levels of free plasma mitochondrial DNA are associated with the onset of chronic GvHD.
Jacob Rozmus, Sabine Ivison, Amina Kariminia, Vivian M Leung, Susanna Sung, Jeff Lipton

Bone Marrow Transplant· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of second-line bosutinib for chronic phase chronic myeloid leukemia over a five-year period: final results of a phase I/II study.
Carlo Gambacorti-Passerini, Jorge E Cortes, Jeff H Lipton, Hagop M Kantarjian, Dong-Wook Kim

Haematologica· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term patient-reported outcomes from an open-label safety and efficacy study of bosutinib in Philadelphia chromosome-positive chronic myeloid leukemia patients resistant or intolerant to prior therapy.
Hagop M Kantarjian, Carla M Mamolo, Carlo Gambacorti-Passerini, Jorge E Cortes, Tim H Brümmendorf, Jeff H Lipton

Cancer· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD56 natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft--host disease: the Canadian Blood and Marrow Transplant Group randomized 0601 study results.
Amina Kariminia, Sabine Ivison, Bernard Ng, Jacob Rozmus, Susanna Sung, Jeff Lipton

Haematologica· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Bosutinib Treatment on Renal Function in Patients With Philadelphia Chromosome-Positive Leukemias.
Jorge E Cortes, Carlo Gambacorti-Passerini, Dong-Wook Kim, Hagop M Kantarjian, Jeff H Lipton

Clin Lymphoma Myeloma Leuk· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term bosutinib for chronic phase chronic myeloid leukemia after failure of imatinib plus dasatinib and/or nilotinib.
Jorge E Cortes, Hanna J Khoury, Hagop M Kantarjian, Jeff H Lipton, Dong-Wook Kim

Am J Hematol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term evaluation of cardiac and vascular toxicity in patients with Philadelphia chromosome-positive leukemias treated with bosutinib.
Jorge E Cortes, H Jean Khoury, Hagop Kantarjian, Tim H Brümmendorf, Michael J Mauro, Jeff H Lipton

Am J Hematol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells.
Amina Kariminia, Shernan G Holtan, Sabine Ivison, Jacob Rozmus, Marie-Josée Hebert, Jeff Lipton

Blood· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors influencing long-term efficacy and tolerability of bosutinib in chronic phase chronic myeloid leukaemia resistant or intolerant to imatinib.
Tim H Brümmendorf, Jorge E Cortes, Hanna J Khoury, Hagop M Kantarjian, Dong-Wook Kim, Jeff H Lipton

Br J Haematol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving diagnostic precision, care and syndrome definitions using comprehensive next-generation sequencing for the inherited bone marrow failure syndromes.
Ibrahim Ghemlas, Hongbing Li, Bozana Zlateska, Robert Klaassen, Conrad V Fernandez, Jeff H Lipton

J Med Genet· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One million haemopoietic stem-cell transplants: a retrospective observational study.
Alois Gratwohl, Marcelo C Pasquini, Mahmoud Aljurf, Yoshiko Atsuta, Helen Baldomero, Jeff Lipton

Lancet Haematol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of bosutinib versus imatinib in the phase 3 BELA trial in newly diagnosed chronic phase chronic myeloid leukemia.
Carlo Gambacorti-Passerini, Jorge E Cortes, Jeff H Lipton, Anna Dmoszynska, Raymond S Wong

Am J Hematol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study.
Alois Gratwohl, Helen Baldomero, Michael Gratwohl, Mahmoud Aljurf, Luis Fernando Bouzas, Jeff Lipton

Haematologica· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemia.
Anna Kreutzman, Taina Jaatinen, Dario Greco, Emmi Vakkila, Johan Richter, Jeff Lipton

Exp Hematol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized trial of dasatinib 100 mg versus imatinib 400 mg in newly diagnosed chronic-phase chronic myeloid leukemia.
Jerald P Radich, Kenneth J Kopecky, Frederick R Appelbaum, Suzanne Kamel-Reid, Wendy Stock, Jeff Lipton

Blood· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation.
Jorge Cortes, Jeff H Lipton, Delphine Rea, Raghunadharao Digumarti, Charles Chuah

Blood· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A non-invasive oral rinse assay predicts bone marrow engraftment and 6 months prognosis following allogeneic hematopoietic stem cell transplantation.
Carol Forster, Guy Aboodi, Jeff Lipton, Michael Glogauer

J Oral Pathol Med· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoietic stem cell transplantation: a global perspective.
Alois Gratwohl, Helen Baldomero, Mahmoud Aljurf, Marcelo C Pasquini, Luis Fernando Bouzas, Jeff Lipton

JAMA· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind trial of pneumococcal vaccination in adult allogeneic stem cell transplant donors and recipients.
Deepali Kumar, Maggie Hong Chen, Brenda Welsh, Deborah Siegal, Isabel Cobos, Jeff Lipton

Clin Infect Dis· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and outcomes of acute myelogenous leukemia patients with very late relapse (>5 years).
Bruno C Medeiros, Mark D Minden, Andre C Schuh, Aaron D Schimmer, Karen Yee, Jeff H Lipton

Leuk Lymphoma· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis